People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Healthtech, Other Technology, Manufacturing / Industrial, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wellvana Health, LLC | — | Healthtech | Series C | $161.2M | $154.3M | 2022 |
| Ovuline, Inc. | — | Other Technology | Series A | $23.1M | $201.8M | 2020 |
| WiserTogether, Inc. | — | Other Technology | Series A | $15.8M | $16.0M | 2017 |
| BEKHealth Corp | — | Other Technology | Series A | $15.3M | $18.4M | 2021 |
| LynkCare, Inc. | — | Other Technology | Series A | $13.6M | $63.8M | 2024 |
| Trilliant Health, Inc. | — | Healthtech | Series A | $12.7M | $285.9M | 2018 |
| Hashed Industries, LLC | — | Manufacturing / Industrial | Series A | $9.0M | $83.2M | 2020 |
| Reimagine Care, Inc. | — | Healthtech | Series A | $8.7M | $7.2M | 2021 |
| Global Pain Center Corp. | — | Other Technology | Series A | $6.2M | $6.7M | 2022 |
| Integrative Life Network, Inc. | — | Other Health Care | Seed | $2.0M | $2.6M | 2025 |
Devin Carty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Devin Carty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Coliano | 2 | 3 |
| Andrew Schwab | 1 | 16 |
| Mark Buffington | 1 | 14 |
| Jonathan Phillips | 1 | 14 |
| Glen Tullman | 1 | 12 |
| Brian Carney | 1 | 10 |
| LEE SHAPIRO | 1 | 10 |
| Don Rainey | 1 | 9 |
| David Levin | 1 | 7 |
| John Crumpler | 1 | 7 |
| Walter Winshall | 1 | 6 |
| Michael Chuisano | 1 | 5 |
| Rock Morphis | 1 | 5 |
| Tamir Meiri | 1 | 5 |
| JON PHILLIPS | 1 | 5 |
| David Shulkin | 1 | 5 |
| Keith Figlioli | 1 | 4 |
| Douglas French | 1 | 4 |
| Steve Skolsky | 1 | 4 |
| Shazi Visram | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.